Stevo - Danhoff thanks for posting.
I keep hearing that term 'gold standard'. Hopefully it comes back to haunt them when the cost of PCR becomes apparent.
John Kelly was very early in saying they had to be careful to not be seen to be taking advantage of the pandemic.
These pathology companies are ripe for the picking - ' community fury' journalistic angle.
What makes them a target is they have not admitted there is space for rapid testing.
It's either / or with them. That smacks of self-interest over community interest.
They are not factoring in the social cost.
Stevo - Danhoff thanks for posting.I keep hearing that term...
-
- There are more pages in this discussion • 1,299 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $12.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 1.9¢ | $3.016K | 150.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 628443 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 291292 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |